Buscar
Mostrando ítems 1-10 de 729
Peptide prodrugs for the treatment of CNS disorders: A perspective for new drugs
(2014-01-01)
The treatment of central nervous system (CNS) diseases is a major challenge. The presence of the barrier intended to protect the brain from unwanted molecules also impairs the efficacy of CNS-targeted drugs. The discovery ...
Peptide Prodrugs for the Treatment of CNS Disorders: A Perspective for New Drugs
(Bentham Science Publ Ltd, 2014-01-01)
The treatment of central nervous system (CNS) diseases is a major challenge. The presence of the barrier intended to protect the brain from unwanted molecules also impairs the efficacy of CNS-targeted drugs. The discovery ...
Wnt/beta-catenin signaling in alzheimers diseaseCNS & NEUROLOGICAL DISORDERS. DRUG TARGETSCNS NEUROL DISORD DRUG TARGETS
(BENTHAM SCIENCE PUBLISHERS, 2016)
Tranquilizing medicinal plants: their CNS effects and active constituents - Our experience
(Taylor & Francis, 2009)
Mental disorder is a psychological or behavioral pattern that occurs in an individual and is thought to cause distress or disability that is not expected as part of normal development or culture. Mental and neurological ...
Potential therapies by stem cell-derived exosomes in cns diseases: focusing on the neurogenic niche
(2016)
Neurodegenerative disorders are one of the leading causes of death and disability and one of the biggest burdens on health care systems. Novel approaches using various types of stem cells have been proposed to treat common ...
Immunomodulation induced by central nervous system-related peptides as a therapeutic strategy for neurodegenerative disorders
(John Wiley & Sons Inc., 2021-10)
Neurodegenerative diseases (NDD) are disorders characterized by the progressive loss of neurons affecting motor, sensory, and/or cognitive functions. The incidence of these diseases is increasing and has a great impact due ...
Peptide Prodrugs for the Treatment of CNS Disorders: A Perspective for New Drugs
(Bentham Science Publ Ltd, 2014)